Choose with context. Fast, side-by-side pharmacology for clinicians treating epilepsy. Select up to four medications to compare.
⌕
All classes / MoAs Benzodiazepines 1,4-benzodiazepines 1,5-benzodiazepines Barbiturates / related Sodium-channel modulation SV2A ligands Gabapentinoids / α2δ ligands Non-benzodiazepine GABAergic GABA-A potentiation GAT-1 inhibition GABA transaminase inhibition T-type calcium currents (proposed) AMPA / kainate antagonism NMDA modulation (proposed) Carbonic anhydrase inhibition Serotonergic mechanisms Cannabinoids Multiple / unresolved mechanisms
All age groups Pediatric use Adult use
All formulations Oral liquid IV formulation Nasal spray Rectal gel Extended release
Any interaction profile Low interaction burden Enzyme inducer Enzyme inhibitor
Try “1,4-benzodiazepines”, “GABA-A”, “SV2A”, or “sodium channel”. Mechanism groups include proposed actions; see each profile for evidence and qualifications.
Comparison tray Add 2–4 medications.
Compare selected drugs Educational reference. Verify patient-specific decisions against the current full prescribing information.
Free during the initial release · No account required Content reviewed September 2026 · U.S. labeling